IBDEI0MZ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10938,1,2,0)
 ;;=2^305.32
 ;;^UTILITY(U,$J,358.3,10938,1,5,0)
 ;;=5^Hallucinogen Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,10938,2)
 ;;=^268238
 ;;^UTILITY(U,$J,358.3,10939,0)
 ;;=305.41^^47^610^24
 ;;^UTILITY(U,$J,358.3,10939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10939,1,2,0)
 ;;=2^305.41
 ;;^UTILITY(U,$J,358.3,10939,1,5,0)
 ;;=5^Anxiolytic Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,10939,2)
 ;;=^331936
 ;;^UTILITY(U,$J,358.3,10940,0)
 ;;=305.42^^47^610^25
 ;;^UTILITY(U,$J,358.3,10940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10940,1,2,0)
 ;;=2^305.42
 ;;^UTILITY(U,$J,358.3,10940,1,5,0)
 ;;=5^Anxiolytic Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,10940,2)
 ;;=^331937
 ;;^UTILITY(U,$J,358.3,10941,0)
 ;;=305.51^^47^610^69
 ;;^UTILITY(U,$J,358.3,10941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10941,1,2,0)
 ;;=2^305.51
 ;;^UTILITY(U,$J,358.3,10941,1,5,0)
 ;;=5^Opioid Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,10941,2)
 ;;=^268244
 ;;^UTILITY(U,$J,358.3,10942,0)
 ;;=305.52^^47^610^70
 ;;^UTILITY(U,$J,358.3,10942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10942,1,2,0)
 ;;=2^305.52
 ;;^UTILITY(U,$J,358.3,10942,1,5,0)
 ;;=5^Opioid Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,10942,2)
 ;;=^268245
 ;;^UTILITY(U,$J,358.3,10943,0)
 ;;=305.61^^47^610^40
 ;;^UTILITY(U,$J,358.3,10943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10943,1,2,0)
 ;;=2^305.61
 ;;^UTILITY(U,$J,358.3,10943,1,5,0)
 ;;=5^Cocaine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,10943,2)
 ;;=^268247
 ;;^UTILITY(U,$J,358.3,10944,0)
 ;;=305.62^^47^610^41
 ;;^UTILITY(U,$J,358.3,10944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10944,1,2,0)
 ;;=2^305.62
 ;;^UTILITY(U,$J,358.3,10944,1,5,0)
 ;;=5^Cocaine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,10944,2)
 ;;=^268248
 ;;^UTILITY(U,$J,358.3,10945,0)
 ;;=305.71^^47^610^16
 ;;^UTILITY(U,$J,358.3,10945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10945,1,2,0)
 ;;=2^305.71
 ;;^UTILITY(U,$J,358.3,10945,1,5,0)
 ;;=5^Amphetamine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,10945,2)
 ;;=^268251
 ;;^UTILITY(U,$J,358.3,10946,0)
 ;;=305.72^^47^610^17
 ;;^UTILITY(U,$J,358.3,10946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10946,1,2,0)
 ;;=2^305.72
 ;;^UTILITY(U,$J,358.3,10946,1,5,0)
 ;;=5^Amphetamine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,10946,2)
 ;;=^268252
 ;;^UTILITY(U,$J,358.3,10947,0)
 ;;=305.91^^47^610^77
 ;;^UTILITY(U,$J,358.3,10947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10947,1,2,0)
 ;;=2^305.91
 ;;^UTILITY(U,$J,358.3,10947,1,5,0)
 ;;=5^Other Drug Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,10947,2)
 ;;=^268259
 ;;^UTILITY(U,$J,358.3,10948,0)
 ;;=305.92^^47^610^78
 ;;^UTILITY(U,$J,358.3,10948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10948,1,2,0)
 ;;=2^305.92
 ;;^UTILITY(U,$J,358.3,10948,1,5,0)
 ;;=5^Other Drug Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,10948,2)
 ;;=^268260
 ;;^UTILITY(U,$J,358.3,10949,0)
 ;;=304.03^^47^610^72
 ;;^UTILITY(U,$J,358.3,10949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10949,1,2,0)
 ;;=2^304.03
 ;;^UTILITY(U,$J,358.3,10949,1,5,0)
 ;;=5^Opioid Dep-Remission
 ;;^UTILITY(U,$J,358.3,10949,2)
 ;;=^268193
 ;;^UTILITY(U,$J,358.3,10950,0)
 ;;=V65.2^^47^611^35
 ;;^UTILITY(U,$J,358.3,10950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10950,1,2,0)
 ;;=2^V65.2
 ;;^UTILITY(U,$J,358.3,10950,1,5,0)
 ;;=5^Malingering
 ;;^UTILITY(U,$J,358.3,10950,2)
 ;;=^92393
 ;;^UTILITY(U,$J,358.3,10951,0)
 ;;=V65.49^^47^611^3
 ;;^UTILITY(U,$J,358.3,10951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10951,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,10951,1,5,0)
 ;;=5^Counseling,Oth Specified
 ;;
 ;;$END ROU IBDEI0MZ
